Keywords: Metalyse, TNKase, STEMI patientss, Myocardial infarction, Boeringer Ingelheim, Genentech

Pharmaco-invasive strategy including Metalyse comparable to primary PCI for STEMI patients

Article | 11 March 2013

Print This

New data presented at the American College of Cardiology 62nd Annual Scientific Sessions and Expo demonstrate that patients with ST ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in